業績

Karino K, Kono M, Kanda M, Atsumi T.

Reply.

Arthritis Rheumatol. in press.

IF=15.483

  • 2023
  • 膠原病グループ
  • 欧文論文/letter

Kato M, Ninagawa K, Atsumi T.

Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: Reply.

Rheumatology (Oxford). in press

IF=7.046

  • 2023
  • 膠原病グループ
  • 欧文論文/letter

Aso K, Fujieda Y, Atsumi T.

Homonymous hemianopsia and headache with mass-like lesion Annals of the Rheumatic Diseases.

IF 19.103

  • 2023
  • 膠原病グループ
  • 欧文論文/症例報告

Scherlinger M, Pan W, Hisada R, Boulougoura A, Yoshida N, Vukelic M, Umeda M, Krishfield S, Tsokos MG, Tsokos GC.

Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity.

Sci Adv. 2022;8(48):eadc9657.

IF = 14.980

  • 2023
  • 膠原病グループ
  • 欧文論文/原著

Oe Y, Nomoto H, Nakamura A, Kuwabara S, Takahashi Y, Yasui A, Izumihara R, Miya A, Kameda H, Cho KY, Atsumi T, Miyoshi H.

Effect of beta-cell function on glucose variability when switching from insulin degludec plus a dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide: preliminary results from a pilot study Int J Endocrinol, in press.

IF:2.803

  • 2023
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Nagasaka K, Amano K, Dobashi H, Nagafuchi H, Sada K, Komagata Y, Yamamura M, Kato M, Endo T, Nakaya I, Takeuchi T, Murakawa Y, Sugihara T, Saito M, Hayashi T, Furuta S, Tamura N, Karasawa K, Banno S, Endo S, Majima M, Kaname S, Arimura Y, Harigai M.

Nation-wide Cohort Study of Remission Induction Therapy using Rituximab in Japanese patients with ANCA-Associated Vasculitis:

effectiveness and safety in the first six months.

Modern Rheumatology. in press.

IF: 2.862

  • 2023
  • 膠原病グループ
  • 欧文論文/原著

Abe N, Kono Michihiro, Kono Michihito*, Katsuyama T, Ohmura K, Sato T, Karino K, Fujieda Y, Kato M, Hasebe R, Murakami M, and Atsumi T.

Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel

vasculitis: a preliminary observational study. Frontiers in Immunology in press

IF=8.786

  • 2023
  • 膠原病グループ
  • 欧文論文/原著

32回日本リウマチ学会北海道・東北支部学術集会 若手リウマチ医奨励賞受賞者セッション 優秀賞 鎌田 和郎先生

  • 2022
  • 膠原病グループ
  • 受賞

Ninagawa K, Kato M, Tsuneta S, Ishizaka S, Ujiie H, Hisada R, Kono M, Fujieda Y, Ito YM, Atsumi T. Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study.

Rheumatology (Oxford), in press

IF:7.046 

  • 2022
  • 膠原病グループ
  • 欧文論文/原著

Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09: 01 allele Takuro Kawamura, Daigo Nakazawa, Saori Nishio, Taiki Isozaki, Maki Komatsumoto, Tatsuya Atsumi.

Modern Rheumatology Case Reports, in press.

IF:2.862

  • 2022
  • 腎臓グループ
  • 欧文論文/症例報告